Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-010279

Chief Financial Officer sold 52,500 shares at $0.88 ($46,347)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mostafa Adam S. Chief Financial Officer 2024-03-11 Sale −52,500 $0.88 $46,347 0 D
Open-market sales · 52,500 sh · avg $0.88 · $46,347
Loading xslF345X05/wk-form4_1710191979.xml…